J9211 HCPCS Level II code: Injection, idarubicin hydrochloride, 5 mg
J9211 is the HCPCS code for “Injection, idarubicin hydrochloride, 5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9211Injection, idarubicin hydrochloride, 5 mg
Short description: Idarubicin hcl injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9211 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1993
Where J9211 sits
- 1J codesDrugs administered other than orally
- 2Active code J9211Injection, idarubicin hydrochloride, 5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9211 mean?
J9211 is the HCPCS code for “Injection, idarubicin hydrochloride, 5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9211?
CMS lists J9211’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9211
All J codesJ9205Injection, irinotecan liposome, 1 mgJ9206Injection, irinotecan, 20 mgJ9207Injection, ixabepilone, 1 mgJ9208Injection, ifosfamide, 1 gramJ9209Injection, mesna, 200 mgJ9210Injection, emapalumab-lzsg, 1 mgJ9212Injection, interferon alfacon-1, recombinant, 1 microgramJ9213Injection, interferon, alfa-2a, recombinant, 3 million unitsJ9214Injection, interferon, alfa-2b, recombinant, 1 million unitsJ9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iuJ9216Injection, interferon, gamma 1-b, 3 million unitsJ9217Leuprolide acetate (for depot suspension), 7.5 mg